|
|
Volumn 46, Issue 9, 2010, Pages 699-731
|
|
A report from the 46th Annual Meeting of the American Society of Clinical Oncology (June 4-8, 2010 - Chicago, Illinois, USA)
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZACITIDINE;
BEVACIZUMAB;
CARBOPLATIN;
CETUXIMAB;
CISPLATIN;
CLOFARABINE;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DAUNORUBICIN;
DEXAMETHASONE;
DOCETAXEL;
DOXORUBICIN;
EPIRUBICIN;
ERLOTINIB;
GEMCITABINE;
IFOSFAMIDE;
IMATINIB;
IRINOTECAN;
METHOTREXATE;
PACLITAXEL;
PANOBINOSTAT;
PEMETREXED;
RITUXIMAB;
SORAFENIB;
SUNITINIB;
TAMOXIFEN;
TAXANE DERIVATIVE;
TRASTUZUMAB;
UNINDEXED DRUG;
VINCRISTINE;
ACUTE GRANULOCYTIC LEUKEMIA;
ACUTE LYMPHOCYTIC LEUKEMIA;
ALVEOLAR SOFT PART SARCOMA;
AMYLOIDOSIS;
ANAPHYLAXIS;
ANDROGEN DEPRIVATION THERAPY;
ANEMIA;
ANGIOIMMUNOBLASTIC LYMPHADENOPATHY;
ANGIOSARCOMA;
ANTIANGIOGENIC ACTIVITY;
ANTINEOPLASTIC ACTIVITY;
ANXIETY;
ARTERY THROMBOSIS;
AUTOTRANSPLANTATION;
B CELL LYMPHOMA;
BILE DUCT CARCINOMA;
BILIARY TRACT CANCER;
BLADDER CANCER;
BLOOD TRANSFUSION;
BONE CANCER;
BONE DENSITY;
BONE MASS;
BONE METASTASIS;
BRAIN LYMPHOMA;
BREAST CANCER;
BURKITT LYMPHOMA;
CACHEXIA;
CANCER ADJUVANT THERAPY;
CANCER CHEMOTHERAPY;
CANCER PAIN;
CANCER SURVIVAL;
CANCER THERAPY;
CARCINOMA;
CARDIOTOXICITY;
CELL PROLIFERATION;
CENTRAL NERVOUS SYSTEM METASTASIS;
CENTRAL NERVOUS SYSTEM TUMOR;
CHEMORADIOTHERAPY;
CHRONIC LYMPHATIC LEUKEMIA;
CHRONIC MYELOID LEUKEMIA;
CHRONIC MYELOMONOCYTIC LEUKEMIA;
COGNITION;
COLORECTAL CANCER;
COMBINATION CHEMOTHERAPY;
CONFERENCE PAPER;
CONGESTIVE HEART FAILURE;
DEPRESSION;
DESMOID TUMOR;
DIABETES MELLITUS;
DIAGNOSTIC PROCEDURE;
DIET;
DIET SUPPLEMENTATION;
DISEASE FREE SURVIVAL;
DOWN REGULATION;
DRUG ACTIVITY;
DRUG COST;
DRUG EFFICACY;
DRUG ERUPTION;
DRUG MEGADOSE;
DRUG TOLERABILITY;
ENDOMETRIUM CANCER;
ENDOMETRIUM CARCINOMA;
ESOPHAGUS CANCER;
ESOPHAGUS METASTASIS;
EWING SARCOMA;
FATIGUE;
FIBROMATOSIS;
FOLLICULAR LYMPHOMA;
FOLLICULITIS;
GASTROINTESTINAL STROMAL TUMOR;
GASTROINTESTINAL TOXICITY;
GENE AMPLIFICATION;
GERM CELL TUMOR;
GLIOMA;
HEAD AND NECK CANCER;
HEMATOLOGIC MALIGNANCY;
HEPATOBLASTOMA;
HODGKIN DISEASE;
HORMONE SUBSTITUTION;
HOSPITALIZATION;
HOT FLUSH;
HUMAN;
HYPERMETABOLISM;
HYPERTENSION;
HYPOGLYCEMIA;
IMMUNE RESPONSE;
IMMUNOGLOBULIN DEFICIENCY;
JOINT CANCER;
KIDNEY CANCER;
KIDNEY CARCINOMA;
KIDNEY DISEASE;
LARGE CELL LYMPHOMA;
LEIOMYOSARCOMA;
LIPOSARCOMA;
LIVER CANCER;
LIVER CARCINOGENESIS;
LIVER CELL CARCINOMA;
LIVER METASTASIS;
LIVER TOXICITY;
LUNG CANCER;
LUNG NON SMALL CELL CANCER;
LUNG SMALL CELL CANCER;
LYMPHOCYTE DEPLETION;
LYMPHOCYTOSIS;
MALE GENITAL TRACT CANCER;
MALIGNANT MESOTHELIOMA;
MANTLE CELL LYMPHOMA;
MELANOMA;
MITOSIS;
MORTALITY;
MULTIPLE MYELOMA;
MYELODYSPLASTIC SYNDROME;
MYELOFIBROSIS;
NAUSEA AND VOMITING;
NEUROBLASTOMA;
NEUROENDOCRINE TUMOR;
NEUTROPENIA;
NON SEMINOMATOUS GERMINOMA;
NONHODGKIN LYMPHOMA;
NOSE SEPTUM PERFORATION;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OSTEOSARCOMA;
OVARY CANCER;
OVERALL SURVIVAL;
PANCREAS CANCER;
PARTIAL MASTECTOMY;
PATIENT MONITORING;
PENIS CANCER;
PERIPHERAL NEUROPATHY;
PERITONEUM CANCER;
PHARMACOGENOMICS;
PLEURA MESOTHELIOMA;
POSITRON EMISSION TOMOGRAPHY;
PROGNOSIS;
PROGRESSION FREE SURVIVAL;
PROMYELOCYTIC LEUKEMIA;
PROSTATE CANCER;
PROTEIN EXPRESSION;
PROTEIN POLYMORPHISM;
RECURRENT DISEASE;
RHABDOMYOSARCOMA;
SALVAGE THERAPY;
SARCOMA;
SEROCONVERSION;
SKIN CANCER;
SKIN CARCINOMA;
SKIN DEFECT;
SKIN TOXICITY;
SOFT TISSUE CANCER;
SOFT TISSUE SARCOMA;
SOLID TUMOR;
SQUAMOUS CELL CARCINOMA;
STEM CELL TRANSPLANTATION;
STOMACH ADENOCARCINOMA;
STOMACH CANCER;
STOMACH PERFORATION;
T CELL LYMPHOMA;
TEA;
THROMBOCYTOPENIA;
THYROID CANCER;
TOXICITY;
TRANSITIONAL CELL CARCINOMA;
UNITED STATES;
UNSPECIFIED SIDE EFFECT;
UTERINE CERVIX CANCER;
UTERUS CANCER;
VASCULAR TUMOR;
VENOUS THROMBOEMBOLISM;
VIRUS HEPATITIS;
BLOOD DISEASE;
NEOPLASM;
HEMATOLOGIC NEOPLASMS;
HUMANS;
ILLINOIS;
NEOPLASMS;
|
|
EID: 79953671118
PISSN: 16993993
EISSN: 16994019
Source Type: Journal
DOI: 10.1358/dot.2010.46.9.1544004 Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (0)
|
